Content
Musk Relaunches Twitter Blue At $8 A Month - But $11 Via App Store
Article By:
Tyler Durden
Read
Tuesday, December 13, 2022 10:30 AM EDT
On Monday, Twitter relaunched its paid subscription option as new owner Elon Musk ambitiously attempts to simultaneously make the platform profitable and less reliant on advertising dollars.
In this article: TSLA
Bahaman Authorities Arrest Sam Bankman-Fried
Article By:
The Tokenist
Read
Tuesday, December 13, 2022 5:16 AM EDT
Attorney General Ryan Pinder announced that the country is expecting the United States to request the extradition of Sam Bankman-Fried.
In this article: FTT-X
Crypto Responds Positively To US Job Losses
Article By:
Simon Peters
Read
Monday, December 12, 2022 7:10 AM EDT
Bitcoin and ether both responded positively late in the week to the latest US Labor Department jobs release - which showed a rise in jobless claims.
In this article: BITCOMP
Elliott Wave Technical Analysis: United Parcel Service Inc., Daily Chart, Monday, Dec. 12
Article By:
Peter Mathers
Read
Monday, December 12, 2022 5:28 AM EDT
UPS has been moving as expected from the last update. We are looking at a move off the 155$ lows as a corrective move, being a three wave structure. We are not forecasting either a three wave move or a triangle in wave (b).
In this article: UPS
Is BREIT Marked To Market?
Article By:
Simon Lack
Read
Sunday, December 11, 2022 7:29 AM EDT
How do you conservatively value illiquid assets in a fund that offers liquidity to existing investors and accepts money from new ones? That’s the unsolvable question inadequately answered by the $125BN Blackstone Real Estate Investment Trust (BREIT)
Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact
Article By:
ChinaBio® Today
Read
Saturday, December 10, 2022 2:20 PM EDT
In a blockbuster agreement, Guangzhou’s Akeso out-licensed ex-China rights to its bispecific PD-1/VEGF candidate in a deal worth up to $5 billion. Summit Therapeutics will pay $500 million upfront and up to $4.5 billion in milestones.
Business Growth In An Economic Recession
Article By:
Bill Conerly
Read
Saturday, December 10, 2022 11:08 AM EDT
Every large change in the business environment brings opportunity. Even a recession, which lowers sales for most companies, offers opportunities for a small number of companies to expand.
Ranked: The World’s 20 Biggest Hedge Funds
Article By:
Jeff Desjardins
Read
Thursday, December 8, 2022 2:30 PM EDT
Collectively, the world’s 15,000 hedge funds manage around $4.5 trillion in assets, weathering economic storms and world events to ensure returns. This visual breaks down the world’s biggest hedge funds in terms of assets under management.
Despite FTX Blowout, Crypto Funding Set To Surpass 2021 Record
Article By:
The Tokenist
Read
Thursday, December 8, 2022 8:30 AM EDT
Crypto funding in 2022 is expected to beat the 2021 record despite a series of collapses, according to PitchBook.
First-Ever US Pacific Offshore Wind Auction Raises Over $750 Million
Article By:
ESG Today
Read
Thursday, December 8, 2022 6:01 AM EDT
The U.S. Department of the Interior announced Wednesday the results of the first-ever offshore wind lease sale for the Pacific region, resulting in more than $757 million in winning bids from 5 companies for leases off the shore of California.
Putting Carbon Back In The Ground
Article By:
Simon Lack
Read
Wednesday, December 7, 2022 6:35 AM EDT
Sometimes a careful, dispassionate analysis of a company’s SEC filings can tell you everything you need to know. Calls with management can improve your understanding but can also color your judgment.
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
Article By:
ChinaBio® Today
Read
Sunday, December 4, 2022 2:29 PM EDT
Full-Life Technologies, a Brussels-Shanghai radiotherapeutics company, will acquire Focus-X Therapeutics for up to $245 million. Using its proprietary peptide engineering technology, Focus-X has built a portfolio of eight radiopharmaceuticals.